Previous Close | 44.77 |
1-Year Change | 153.22% |
6-Months Change | 55.02% |
3-Months Change | 42.44% |
Moving Avg (50d) | 40.241 |
Moving Avg (200d) | 30.721 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.58B |
Beta (3-Years) | 1.37 |
Revenue Growth (ttm) | -100% |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -42.57% |
EPS (ttm) | -2.63 |
PE Ratio (ttm) | -17.02 |
Dividend Yield | % |
Asset Description: | Protagonist Therapeutics, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-18 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
45.665 | 47.009 | 47.904 | 49.247 | 51.486 | 53.724 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |